CHRONIC HEART FAILURE (CHF) IN THE CZECH REPUBLIC: COST-OF-ILLNESS ANALYSIS & DISEASE BURDEN BASED ON AHEAD REGISTRY DATA MINING

被引：0
|
作者：
Spinar, J. [1 ]
Parenica, J. [1 ]
Klimes, J. [2 ]
Vesela, V. [2 ]
Blahovcova, M. [2 ]
Dostal, F. [2 ]
Vonka, R. [2 ]
机构：
[1] Univ Hosp Brno, Brno, Czech Republic
[2] Novartis Sro, Prague, Czech Republic
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1201
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV55
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [31] Influence of body mass index and metabolic-inflammatory variables on prognosis of outpatients with chronic heart failure. Data from the Italian Network on Congestive Heart Failure (IN-CHF Registry)
    Baldasseroni, S
    Urso, R
    Gonzini, L
    De Biase, L
    De Cian, F
    Minneci, S
    Castiglioni, G
    Maggioni, AP
    EUROPEAN HEART JOURNAL, 2003, 24 : 607 - 607
  • [32] BETA BLOCKER THERAPY IS WELL TOLERATED IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CHRONIC HEART FAILURE: CLINICAL INFORMATION MANAGER FOR HEART FAILURE REGISTRY ANALYSIS
    Bell, R.
    Houston-Feenstra, L.
    Fuller, C.
    Petersen, D. K.
    Chiong, J. R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 188 - 188
  • [33] NATIONWIDE ANNUAL HEALTH INSURANCE TREATMENT COST OF HEART FAILURE IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA
    Endrei, D.
    Sebestyen, A.
    Gazso, T.
    Molics, B.
    Acs, P.
    Habon, T.
    Boncz, I
    VALUE IN HEALTH, 2019, 22 : S542 - S542
  • [34] Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: Data from the IN-CHF Registry
    Baldasseroni, S.
    Urso, R.
    Maggioni, A. P.
    Orso, F.
    Fabbri, G.
    Marchionni, N.
    Tavazzi, L.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (05) : 442 - 448
  • [35] Genomic analysis and data mining of patients with chronic heart failure may provide novel tehrapy of adenosine
    Kitakaze, M
    Kim, J
    Hori, M
    Tomoike, H
    Kitamura, S
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (11) : A13 - A13
  • [36] Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017
    Agudelo-Botero, Marcela
    Valdez-Ortiz, Rafael
    Giraldo-Rodriguez, Liliana
    Cecilia Gonzalez-Robledo, Maria
    Mino-Leon, Dolores
    Fernanda Rosales-Herrera, Maria
    Cahuana-Hurtado, Lucero
    Enrique Rojas-Russell, Mario
    Alberto Davila-Cervantes, Claudio
    BMJ OPEN, 2020, 10 (03):
  • [37] COST/UTILITY ANALYSIS (CUA) OF VALSARTAN FOR THE TREATMENT OF CONGESTIVE HEART FAILURE (CHF) IN ITALY BASED ON THE VAL-HEFT TRIAL
    Pradelli, L.
    Iannazzo, S.
    Zaniolo, O.
    VALUE IN HEALTH, 2008, 11 (06) : A403 - A404
  • [38] Use of High Dose Carvedilol in Chronic Heart Failure With Chronic Obstructive Pulmonary Disease: CIM-HF Registry Analysis
    Harris, Michelle M.
    Houston-Feenstra, Linda
    Chiong, Jun R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A160 - A161
  • [39] THE INPATIENT BURDEN OF MEDICARE PATIENTS WITH HEART FAILURE, CHRONIC KIDNEY DISEASE AND A HISTORY OF STROKE: A RETROSPECTIVE DATABASE ANALYSIS
    Imhoff, R. J.
    Thomas, J. T.
    VALUE IN HEALTH, 2017, 20 (05) : A268 - A268
  • [40] Macromastia: an economic burden? A disease cost analysis based on real-world data in Germany
    Jud, Sebastian M.
    Brendle-Behnisch, Anne
    Hack, Carolin C.
    Preuss, Caroline
    Arkudas, Andreas
    Horch, Raymund E.
    Beckmann, Matthias W.
    Lux, Michael P.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (02) : 521 - 531
12345